| Entry |
|
|---|
| Name |
Tolazamide (JAN/USP/INN);
Tolinase (TN) |
|---|
| Formula |
C14H21N3O3S
|
|---|
| Exact mass |
311.1304
|
|---|
| Mol weight |
311.3998
|
|---|
| Structure |
|
|---|
| Class |
|
|---|
| Remark |
|
|---|
| Efficacy |
Antidiabetic, Hypoglycemic, Sulfonylurea receptor agonist |
|---|
| Disease |
Type II diabetes mellitus [DS: H00409] |
|---|
| Comment |
Sulfonylurea
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07018 | Sulfonamide derivatives - hypoglycemic agents |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
A10BB Sulfonylureas
A10BB05 Tolazamide
D00379 Tolazamide (JAN/USP/INN)
Drug groups [BR:br08330]
Antidiabetic agent
DG01508 Sulfonylurea receptor agonist
DG01734 Sulfonylurea
D00379 Tolazamide
DG02044 Hypoglycemic agent
DG01734 Sulfonylurea
D00379 Tolazamide
Target-based classification of drugs [BR:br08310]
Transporters
ABC transporters
ABCC subfamily
ABCC8(SUR1)/KCNJ11(KIR6.2)
D00379 Tolazamide (JAN/USP/INN)
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 21
1 C8y C 15.9600 -16.6600
2 C8x C 15.9600 -18.0600
3 C8x C 14.7700 -18.7600
4 C8y C 13.4400 -18.0600
5 C8x C 13.4400 -16.6600
6 C8x C 14.7700 -15.9600
7 C1a C 12.2500 -18.7600
8 S4a S 17.1500 -15.9600
9 N1b N 18.3400 -16.6600
10 C5a C 19.5300 -15.9600
11 N1b N 20.7200 -16.6600
12 N1y N 21.9100 -15.9600
13 O5a O 19.5300 -14.5600
14 O3c O 16.1700 -14.9800
15 O3c O 18.1300 -14.9800
16 C1x C 21.9100 -14.5600
17 C1x C 23.0300 -13.5800
18 C1x C 24.3600 -13.9300
19 C1x C 24.9900 -15.2600
20 C1x C 24.3600 -16.5200
21 C1x C 23.0300 -16.8000
BOND 22
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 1 8 1
9 8 9 1
10 9 10 1
11 10 11 1
12 11 12 1
13 10 13 2
14 8 14 2
15 8 15 2
16 18 19 1
17 16 12 1
18 19 20 1
19 17 18 1
20 12 21 1
21 16 17 1
22 20 21 1
|
|---|
